• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell: Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

tetano

Editor, Senior Moderator
[h=1]Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy[/h] Taia T. Wang[SUP]7[/SUP]
, Jad Maamary[SUP]7[/SUP]
, Gene S. Tan
, Stylianos Bournazos
, Carl W. Davis
, Florian Krammer
, Sarah J. Schlesinger
, Peter Palese
, Rafi Ahmed
, Jeffrey V. Ravetch
article_notepad.gif

[SUP]7[/SUP]Co-first author


DOI: http://dx.doi.org/10.1016/j.cell.2015.06.026 |


[h=2]Highlights[/h]
  • ?Dynamic changes in Fc glycan composition following influenza vaccination
  • ?Sialylated Fc glycan abundance on anti-HA IgG predicts vaccine response
  • ?Sialylated Fc immune complexes engage CD23 and BCR to modulate affinity maturation
  • ?IgGs elicited by sialylated Fc immune complexes protect broadly against H1 viruses


[h=2]Summary[/h] Protective vaccines elicit high-affinity, neutralizing antibodies by selection of somatically hypermutated B cell antigen receptors (BCR) on immune complexes (ICs). This implicates Fc-Fc receptor (FcR) interactions in affinity maturation, which, in turn, are determined by IgG subclass and Fc glycan composition within ICs. Trivalent influenza virus vaccination elicited regulation of anti-hemagglutinin (HA) IgG subclass and Fc glycans, with abundance of sialylated Fc glycans (sFc) predicting quality of vaccine response. We show that sFcs drive BCR affinity selection by binding the Type-II FcR CD23, thus upregulating the inhibitory FcγRIIB on activated B cells. This elevates the threshold requirement for BCR signaling, resulting in B cell selection for higher affinity BCR. Immunization with sFc HA ICs elicited protective, high-affinity IgGs against the conserved stalk of the HA. These results reveal a novel, endogenous pathway for affinity maturation that can be exploited for eliciting high-affinity, broadly neutralizing antibodies through immunization with sialylated immune complexes.

http://www.cell.com/abstract/S0092-8674(15)00710-2
 
Back
Top